Superior Vena Cava Resection and Reconstruction in Thoracic Malignancy / 대한흉부외과학회지
The Korean Journal of Thoracic and Cardiovascular Surgery
;
: 273-279, 2010.
Article
Dans Coréen
| WPRIM
| ID: wpr-223920
ABSTRACT
BACKGROUND:
The benefit of superior vena cava (SVC) resection in thoracic malignancies remains controversial. We analyzed the results of extended resection in patients with thoracic malignancy involving the SVC. MATERIAL ANDMETHOD:
From March 2000 to March 2009, we performed surgical resection and reconstruction in 18 thoracic malignancies involving the SVC. Ten male and 8 female enrolled and their mean age was 56 years.RESULT:
SVC reconstruction was performed in 9 patients with polytetrafluoroethylene (PTFE) graft. Primary closure was possible in 6 patients by partially clamping the SVC. Patch angioplasty was performed in 3 patients with PTFE or autologous pericardial patch. Three-year survival was 58.0% and median survival time was 24.5 months. Disease specific survival and recurrence free survival were not significantly different between lung cancer and mediastinal malignancy. Obstruction of graft was detected in 4 patients during follow-up; SVC graft obstruction in 1 patient, and accessory graft between the innominate vein and right atrium in 3 patients.CONCLUSION:
Extended resection of thoracic malignancies involving the SVC was a feasible method in selected patients. Although the morbidity rate was relatively high, mid-term survival was acceptable when complete resection was possible.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Polytétrafluoroéthylène
/
Récidive
/
Veine cave supérieure
/
Veines brachiocéphaliques
/
Angioplastie
/
Constriction
/
Transplants
/
Atrium du coeur
/
Tumeurs du poumon
/
Tumeurs du médiastin
Limites du sujet:
Femelle
/
Humains
/
Mâle
langue:
Coréen
Texte intégral:
The Korean Journal of Thoracic and Cardiovascular Surgery
Année:
2010
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS